GAUZ:NASDAQGauzy Ltd. Analysis
Data as of 2026-08-13 - not real-time
$0.43
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Gauzy Ltd. is priced at $0.4270 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have lost 11.0%. RSI sits at 55.5, which reads as neutral, and MACD momentum is bullish. Watch $0.2300 as support and $0.9700 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 0.7 sits below the sector average of 36.3. Revenue is contracting at 17.8% on a -39.6% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 181.2%, a beta of 1.38 and a maximum drawdown of 96.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Valuation screens as undervalued: a P/E of 0.7 sits below the sector average of 36.3. Revenue is contracting at 17.8% on a -39.6% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 181.2%, a beta of 1.38 and a maximum drawdown of 96.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
Detailed price information for Gauzy Ltd GAUZ-Q from The Globe and Mail including charting and trades.ADVFN23dForm 6-K - Report of foreign issuer Rules 13a-16 and 15d-16 As Gauzy Ltd.3yGauzy Ltd.View Gauzy Ltd. GAUZ stock quote prices, financial information, real-time forecasts, and company news from...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.15
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 0.7 versus sector average of 36.3
- Trading below the 200-day average of 1.15
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 0.7 versus sector average of 36.3
- Negative profit margin of -39.6%
- Negative return on equity of -94.5%
Key Metrics & Analysis
Financial Health
Revenue Growth-17.80%
Profit Margin-39.63%
P/E Ratio0.7
ROE-94.46%
ROA-13.03%
Debt/Equity354.31
P/B Ratio0.4
Op. Cash Flow$-20112000
Free Cash Flow$-10643000
Industry P/E36.3
Technical Analysis
TrendBearish
RSI55.5
Support$0.23
Resistance$0.97
MA 20$0.35
MA 50$0.46
MA 200$1.15
MACDBullish
VolumeIncreasing
Fear & Greed Index95.36
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.38
Volatility181.23%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.